# Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence

> **NCT00003858** · PHASE2 · WITHDRAWN · sponsor: **Alliance for Clinical Trials in Oncology**

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** mitoxantrone hydrochloride

## Key facts

- **NCT ID:** NCT00003858
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was not activated.
- **Last updated:** 2016-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003858, "Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00003858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*